26
|
Launay D, Savale L, Berezne A, Le Pavec J, Hachulla E, Mouthon L, Sitbon O, Lambert B, Gaudric M, Jais X, Stephan F, Hatron PY, Lamblin N, Vignaux O, Cottin V, Farge D, Wallaert B, Guillevin L, Simonneau G, Mercier O, Fadel E, Dartevelle P, Humbert M, Mussot S. Lung and heart-lung transplantation for systemic sclerosis patients. A monocentric experience of 13 patients, review of the literature and position paper of a multidisciplinary Working Group. Presse Med 2014; 43:e345-63. [DOI: 10.1016/j.lpm.2014.01.020] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/11/2013] [Accepted: 01/23/2014] [Indexed: 12/14/2022] Open
|
27
|
Benarous L, Terrier B, Berezne A, Dunogué B, Laborde-Casterot H, Cohen P, Puéchal X, Costedoat-Chalumeau N, Le Jeunne C, Choudat D, Mouthon L, Guillevin L. Étude comparative de la qualité de vie chez les patients atteints de vascularites associées aux ANCA. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.03.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
28
|
Ghrénassia E, Avouac J, Khanna D, Derk CT, Distler O, Suliman YA, Airo P, Carreira PE, Foti R, Granel B, Berezne A, Cabane J, Ingegnoli F, Rosato E, Caramaschi P, Hesselstrand R, Walker UA, Alegre-Sancho JJ, Zarrouk V, Agard C, Riccieri V, Schiopu E, Gladue H, Steen VD, Allanore Y. Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case-control study. J Rheumatol 2013; 41:99-105. [PMID: 24293584 DOI: 10.3899/jrheum.130386] [Citation(s) in RCA: 60] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
OBJECTIVE To estimate the prevalence, determine the subgroups at risk, and the outcomes of patients with systemic sclerosis (SSc) and gastric antral vascular ectasia (GAVE). METHODS We queried the European League Against Rheumatism Scleroderma Trials and Research (EUSTAR) network for the recruitment of patients with SSc-GAVE. Each case was matched for cutaneous subset and disease duration with 2 controls with SSc recruited from the same center, evaluated at the time the index case made the diagnosis of GAVE. SSc characteristics were recorded at the time GAVE occurred and the last observation was collected to define the outcomes. RESULTS Forty-nine patients with SSc and GAVE were included (24 with diffuse cutaneous SSc) and compared to 93 controls with SSc. The prevalence of GAVE was estimated at about 1% of patients with SSc. By multivariate analysis, patients with SSc-GAVE more frequently exhibited a diminished (< 75%) DLCO value (OR 12.8; 95% CI 1.9-82.8) despite less frequent pulmonary fibrosis (OR 0.2; 95% CI 0.1-0.6). GAVE was also associated with the presence of anti-RNA-polymerase III antibodies (OR 4.6; 95% CI 1.2-21.1). SSc-GAVE was associated with anemia (82%) requiring blood transfusion (45%). Therapeutic endoscopic procedures were performed in 45% of patients with GAVE. After a median followup of 30 months (range 1-113 months), survival was similar in patients with SSc-GAVE compared to controls, but a higher number of scleroderma renal crisis cases occurred (12% vs 2%; p = 0.01). CONCLUSION GAVE is rare and associated with a vascular phenotype, including anti-RNA-polymerase III antibodies, and a high risk of renal crisis. Anemia, usually requiring blood transfusions, is a common complication.
Collapse
|
29
|
Guillet H, Berezne A, Guedj M, Rabot N, Meney J, Rouzaud D, Halimi JM, Le Lez ML, Diot E, Goupille P, Mouthon L, Costedoat-Chalumeau N. La pseudo-rétinopathie de Purtscher : une manifestation vasculaire rare au cours de la sclérodermie systémique. Rev Med Interne 2013. [DOI: 10.1016/j.revmed.2013.10.242] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
30
|
Thiébaut M, Terrier B, Menacer S, Berezne A, Bussone G, Goulvestre C, Bellance R, Guillevin L, Vignaux O, Mouthon L. Antisignal recognition particle antibodies-related cardiomyopathy. Circulation 2013; 127:e434-6. [PMID: 23381964 DOI: 10.1161/circulationaha.112.118877] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
31
|
Ghrenassia E, Avouac J, Derk C, Airo P, Khanna D, Berezne A, Tiev K, Ingegnoli F, Rosato E, Caramaschi P, Hesselstrand R, Riccieri V, Bae S, Steen V, Allanore Y. FRI0242 Watermelon stomach in systemic sclerosis: A EUSTAR case-control study. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.2699] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
32
|
Berezne A, Seror R, Bussone G, Morell-Dubois S, Guillevin L, Mouthon L. AB0787 Influence of digital ulcer healing on disability and daily activity limitations in systemic sclerosis. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.787] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
33
|
Ripoll E, Ripoll E, Goma M, Bolanos N, Herrero I, Bestard O, Cruzado JM, Grinyo JM, Torras J, Venot M, Venot M, Nochy D, Caudwell V, Jacquot C, Hill G, Piette JC, Daugas E, Wilde B, Thewissen M, Van Paassen P, Hilhorst M, Damoiseaux J, Witzke O, Cohen Tervaert JW, Chen N, LI X, Zhang W, Shen P, Yu H, Chen Y, Ren H, Ni L, Lebas C, Guillevin L, Berezne A, Seror R, Teixeira L, Pourrat J, Mahr A, Hachulla E, Agard C, Cabane J, Vanhille P, Harle JR, Deleveaux I, Mouthon L. Autoimmune systemic diseases. Nephrol Dial Transplant 2012. [DOI: 10.1093/ndt/gfs205] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
34
|
Berezne A, Seror R, Bussone G, Nguyen C, Morell-Dubois S, Fois E, Guillevin L, Mouthon L, Mouthon L, Carpentier P, Khau Van Kien A, Clerson P, Maillard H, Hachulla E, Frances C, Diot E, Lok C, Puzenat E, Sparsa A, Berezne A, Gressin V, Richard MA, Saketkoo LA, Escorpizo R, Keen K, Fligelstone K, Distler O, Assassi S, Leyva A, Mayes M, Sharif R, Nair D, Fischbach M, Nguyen N, Reveille J, Gonzalez E, McNearney T, Riccieri V, Sciarra I, Maset L, Passi L, Stefanantoni K, Vasile M, Scarno A, Spadaro A. S.11.1 Influence of digital ulcer healing on disability and daily activity limitations in SSc. Rheumatology (Oxford) 2012. [DOI: 10.1093/rheumatology/ker485] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
35
|
Mouthon L, Carpentier P, Lok C, Clerson P, Puzenat E, Hachulla E, Frances C, Berezne A, Khau Van Kien-Wautot A, Diot E, Gressin V, Richard MA. Évaluation de l’impact de la survenue répétée d’ulcères digitaux ischémiques sur le handicap fonctionnel des mains de patients sclérodermiques (ECLIPSE). Description de la cohorte à l’inclusion. Rev Med Interne 2011. [DOI: 10.1016/j.revmed.2011.10.352] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
36
|
Guillevin L, Berezne A, Seror R, Teixeira L, Pourrat J, Mahr A, Hachulla E, Agard C, Cabane J, Vanhille P, Harle JR, Deleveaux I, Mouthon L. Scleroderma renal crisis: a retrospective multicentre study on 91 patients and 427 controls. Rheumatology (Oxford) 2011; 51:460-7. [DOI: 10.1093/rheumatology/ker271] [Citation(s) in RCA: 124] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
|
37
|
Gobert D, Bussel JB, Cunningham-Rundles C, Galicier L, Dechartres A, Berezne A, Bonnotte B, DeRevel T, Auzary C, Jaussaud R, Larroche C, LeQuellec A, Ruivard M, Seve P, Smail A, Viallard JF, Godeau B, Hermine O, Michel M. Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients. Br J Haematol 2011; 155:498-508. [PMID: 21981575 DOI: 10.1111/j.1365-2141.2011.08880.x] [Citation(s) in RCA: 111] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Abstract
Patients with common variable immunodeficiency (CVID) are at high risk of developing immune thrombocytopenia (ITP) and/or autoimmune haemolytic anaemia (AHA). Given their underlying immunodeficiency, immunosuppressive treatment of these manifestations may increase the risk of infection. To assess efficacy and safety of rituximab in patients with CVID-associated ITP/AHA, a multicentre retrospective study was performed. Thirty-three patients, 29 adults and four children, were included. Patients received an average of 2·6 treatments prior to rituximab including steroids, intravenous immunoglobulin and splenectomy (21%). The median ITP/AHA duration at time of first rituximab administration was 12 months [range 1-324] and the indication for using rituximab was ITP (22 cases), AHA (n = 5) or both (n = 7); 1 patient was treated sequentially for ITP and then AHA. The overall initial response rate to rituximab was 85% including 74% complete responses. After a mean follow-up of 39 ± 30 months after rituximab first administration, 10 of the initial responders relapsed and re-treatment with rituximab was successful in 7/9. Severe infections occurred after rituximab in eight adults (24%), four of whom were not on immunoglobulin replacement therapy. In conclusion, rituximab appears to be highly effective and relatively safe for the management of CVID-associated severe immune cytopenias.
Collapse
|
38
|
Abid H, Denys P, Berezne A, Giuliano F, Sanchez K, Poiraudeau S, Mouthon L. Evaluation of bladder-sphincter disorders sclerodermia: 69 patients. Ann Phys Rehabil Med 2011. [DOI: 10.1016/j.rehab.2011.07.152] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
39
|
Abid H, Denys P, Berezne A, Giuliano F, Sanchez K, Poiraudeau S, Mouthon L. Évaluation des troubles vesicosphincteriens dans la sclerodermie : à propos de 69 patients. Ann Phys Rehabil Med 2011. [DOI: 10.1016/j.rehab.2011.07.142] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
40
|
Launay D, Humbert M, Berezne A, Cottin V, Allanore Y, Couderc LJ, Bletry O, Yaici A, Hatron PY, Mouthon L, Le Pavec J, Clerson P, Hachulla E. Clinical Characteristics and Survival in Systemic Sclerosis-Related Pulmonary Hypertension Associated With Interstitial Lung Disease. Chest 2011; 140:1016-1024. [DOI: 10.1378/chest.10-2473] [Citation(s) in RCA: 70] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
41
|
Feuillet S, Louis L, Bergeron A, Berezne A, Dubreuil ML, Polivka M, Oksenhendler E, Tazi A. Pulmonary Langerhans cell histiocytosis associated with Hodgkin's lymphoma. Eur Respir Rev 2011; 19:86-8. [PMID: 20956172 DOI: 10.1183/09059180.00007509] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
|
42
|
Sanchez K, Denys P, Berezne A, Giuliano F, Abid H, Poiraudeau S, Mouthon L. Troubles vésicosphinctériens et génitosexuels chez 83 patients atteints d’une sclérodermie systémique. Rev Med Interne 2010. [DOI: 10.1016/j.revmed.2010.10.077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
43
|
Berezne A, Nguyen C, Bussone G, Morell-Dubois S, de Menthon M, Föis E, Gressin V, Guillevin L, Poiraudeau S, Mouthon L. Influence de la cicatrisation des ulcères digitaux sur le handicap global et de la main au cours de la sclérodermie systémique : étude prospective. Rev Med Interne 2010. [DOI: 10.1016/j.revmed.2010.10.081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
44
|
Nguyen C, Poiraudeau S, Mestre-Stanislas C, Rannou F, Berezne A, Papelard A, Choudat D, Revel M, Guillevin L, Mouthon L. Employment status and socio-economic burden in systemic sclerosis: a cross-sectional survey. Rheumatology (Oxford) 2010; 49:982-9. [DOI: 10.1093/rheumatology/kep400] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
45
|
Hachulla E, Launay D, Yaici A, Berezne A, de Groote P, Sitbon O, Mouthon L, Guillevin L, Hatron PY, Simonneau G, Clerson P, Humbert M. Pulmonary arterial hypertension associated with systemic sclerosis in patients with functional class II dyspnoea: mild symptoms but severe outcome. Rheumatology (Oxford) 2010; 49:940-4. [PMID: 20144930 DOI: 10.1093/rheumatology/kep449] [Citation(s) in RCA: 41] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
OBJECTIVE To describe the history of SSc-associated pulmonary arterial hypertension (SSc-PAH) in patients with New York Heart Association (NYHA) functional class (FC) II dyspnoea at diagnosis. METHODS Data at the time of diagnosis were collected and analysed retrospectively for 77 consecutive patients with SSc-PAH. RESULTS Twelve patients (15.6%) presented with PAH and NYHA FC II dyspnoea. After a mean follow-up of 44 months, only 4 out of the 12 PAH patients remained stable in FC II, while 8 showed worsening to FC III or IV. Three patients died during the observation period; two from PAH and one from rectal cancer. Survival in patients in FC II at diagnosis was 100, 91 and 80% at 1, 2 and 3 years, respectively. CONCLUSIONS A majority of patients with mildly symptomatic SSc-PAH in NYHA FC II at diagnosis have a severe disease with poor prognosis.
Collapse
|
46
|
Berezne A, Seror R, Morell-Dubois S, de Menthon M, Fois E, Dzeing-Ella A, Dupuis F, Guillevin L, Poiraudeau S, Mouthon L. Impact des ulcères digitaux sur l’activité professionnelle et occupationnelle au cours de la sclérodermie systémique. Rev Med Interne 2009. [DOI: 10.1016/j.revmed.2009.10.061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
47
|
Hachulla E, Launay D, Mouthon L, Sitbon O, Berezne A, Guillevin L, Hatron PY, Simonneau G, Clerson P, Humbert M. Is Pulmonary Arterial Hypertension Really a Late Complication of Systemic Sclerosis? Chest 2009; 136:1211-1219. [DOI: 10.1378/chest.08-3042] [Citation(s) in RCA: 97] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
48
|
Ranque B, Authier FJ, Le-Guern V, Pagnoux C, Berezne A, Allanore Y, Launay D, Hachulla E, Kahan A, Cabane J, Gherardi R, Guillevin L, Mouthon L. A descriptive and prognostic study of systemic sclerosis-associated myopathies. Ann Rheum Dis 2008; 68:1474-7. [DOI: 10.1136/ard.2008.095919] [Citation(s) in RCA: 67] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Objectives:To describe the clinical characteristics and muscle pathological features of patients with systemic sclerosis (SSc) and myopathy and analyse their impact on muscle outcome.Methods:Thirty-five patients with myopathy and available muscle biopsy were restrospectively investigated from the charts of four hospital centres.Results:Twenty-six (74%) cases had diffuse SSc. The median time from SSc diagnosis was 5 years (range 0–23) at myopathy onset. The main myopathological features were mononuclear inflammation (63%), muscle atrophy (60%), necrosis (59%), regeneration (44%), fibrosis (24%) or microangiopathy (27%). After a median follow-up of 4.4 years, 24 patients (69%) showed complete or partial muscle remission. Only histological muscle inflammation was associated with good muscle prognosis in multivariate analysis (odds ratio 44.7, 95% CI 2.8 to 704.7). Patients without muscle inflammation had a poor response to corticosteroids (38% favourable response vs 90% in patients with inflammation).Conclusion:Muscle histopathology is critical in the therapeutic management of SSc-associated myopathy.
Collapse
|
49
|
Mestre C, Poiraudeau S, Berezne A, Rannou F, Guilpain P, Pagnoux C, Revel M, Guillevin L, Mouthon L. Influence du mode de recrutement des patients sclérodermiques sur la sévérité de la maladie, le retentissement fonctionnel et la qualité de vie. Rev Med Interne 2008. [DOI: 10.1016/j.revmed.2008.03.309] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
50
|
Terrier B, Fakhouri F, Berezne A, Bouldouyre MA, Guilpain P, Sogni P, Terris B, Noël LH, Guillevin L, Mouthon L. Osteomalacia revealing celiac disease and primary biliary cirrhosis-related Fanconi syndrome in a patient with systemic sclerosis. Clin Exp Rheumatol 2008; 26:467-470. [PMID: 18578972] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
Systemic sclerosis (SSc) may affect the gastrointestinal tract and cause very rarely malabsorption syndrome related to bacterial overgrowth. Malabsorption syndrome may be responsible for weight loss, diarrhea, osteomalacia, and iron and vitamins deficiency. We report the case of a SSc patient who developed osteomalacia caused by the combination of two exceptional conditions in the setting of SSc: celiac disease (CD) and primary biliary cirrhosis (PBC)-related Fanconi syndrome. Oral prednisone with angiotensin-converting enzyme inhibitors, was initiated because of active lesions of tubulitis, and led to the complete regression of bone pains, and by the improvement of renal function and regression of the features of proximal tubulopathy. Thus, in the presence of vitamin deficiencies in a patient with SSc, together with a search for malabsorption syndrome secondary to bacterial overgrowth, CD and/or PBC-associated Fanconi syndrome should be investigated.
Collapse
|